Carcinoembryonic Antigen Market Insights: Share, Size, And Outlook 2035
The global Carcinoembryonic Antigen market is demonstrating steady expansion, driven by rising cancer prevalence and increasing reliance on tumor biomarkers for diagnosis and monitoring. The market was valued at USD 2.63 billion in 2025 and is projected to reach approximately USD 4.89 billion by 2035, registering a compound annual growth rate (CAGR) of 6.4% during the forecast period (2026–2035).
